| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.035 | 0.9 |